Why aging clocks need multiple layers of biological data

Biological aging is a multidimensional phenomenon that cannot be reduced to a single molecular marker. While early aging clocks—such as Horvath's and Hannum's—were trained exclusively on DNA methylation patterns and demonstrated ability to identify accelerated aging, later generations have expanded scope to include metabolomics, clinical biomarkers, and mortality data, showing superior performance in predicting health trajectories. The fundamental problem is that aging does not progress uniformly: organs age asynchronously, with coordinated changes across genetic, epigenetic, transcriptomic, proteomic, and metabolic dimensions that interact dynamically across tissues. Researchers argue that future aging clocks should integrate multiple omics sources simultaneously, capturing these systemic interactions rather than isolated molecular changes. For the biohacker and longevity researcher interested in intervention assessment, this means the next generation of biological age evaluations will be significantly more predictive of actual disease risk and mortality than current tools, though lack of longitudinal datasets and technical variability between platforms remain immediate practical obstacles.